Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE)

INTRODUCTION: Patients with rheumatoid arthritis (RA) with poor prognostic factors, such as seropositivity for anti-citrullinated protein antibodies and early erosions, may benefit from early intensive treatment. However, information to guide physicians on the best choice of therapy in these patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Weinblatt, Michael, Ahmad, Harris, Maldonado, Michael A., Alemao, Evo, Ye, June, Schiff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858431/
https://www.ncbi.nlm.nih.gov/pubmed/31642045
http://dx.doi.org/10.1007/s40744-019-00174-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858431/
https://www.ncbi.nlm.nih.gov/pubmed/31642045
http://dx.doi.org/10.1007/s40744-019-00174-7

Ejemplares similares